Next 10 |
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
2024-04-24 15:42:21 ET More on Novo Nordisk Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront 3.6M Medicare patients could qualify f...
2024-04-24 13:02:30 ET Summary Madrigal Pharmaceuticals, Inc. recently received FDA approval for its lead candidate resmetirom, targeting a liver condition called NASH. The NASH market is projected to reach $50 billion by 2035, making it a significant opportunity for Madrigal Phar...
2024-04-24 10:27:55 ET More on Novo Nordisk Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront TikTok to restrict weight loss drug pr...
2024-04-24 10:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio meaningfully beat the benchmark MSCI EAFE Index, as well as the seconda...
2024-04-24 06:40:00 ET Eli Lilly 's (NYSE: LLY) Zepbound has shown it has what it takes to become a blockbuster. The weight-loss drug, following regulatory approval late last year, brought in $175 million in revenue in just its first few weeks on the market. Doctors and their patien...
2024-04-24 05:09:27 ET Summary JPMorgan Active Growth ETF is an actively managed ETF focused on companies with above-average earnings growth and leading competitive positions. The portfolio is heavily invested in large companies of the technology, consumer discretionary and commun...
2024-04-24 04:30:00 ET Summary Equity markets had a solid start to the year, with the S&P 500 up 10.6%. The Madison Sustainable Equity Fund lagged the S&P 500 for the first quarter. As we exited the quarter, sticky inflation began to put into question the timing and number...
2024-04-23 13:12:48 ET Summary The recent lack of M&A activity and rising interest rates have helped trigger an approximate 20% decline in small-cap biotech equities. Drug blockbusters facing key patent expirations and Big Pharma's surplus of cash suggest increased M&A vol...
2024-04-23 11:26:33 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Remains The Better Buy After A Moderate Pullback Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly buys injectable medicine manufact...
News, Short Squeeze, Breakout and More Instantly...
Eli Lilly and Company Company Name:
LLY Stock Symbol:
NYSE Market:
The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing Novo Nordisk A/S (NYSE:NVO) ‘s pric...
2024-04-24 06:40:00 ET Eli Lilly 's (NYSE: LLY) Zepbound has shown it has what it takes to become a blockbuster. The weight-loss drug, following regulatory approval late last year, brought in $175 million in revenue in just its first few weeks on the market. Doctors and their patien...
On Monday, Eli Lilly and Company (NYSE:LLY) agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. Th...